Stocks News

LAST PRICE
311.4200
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
124.5700/ 2
Ask / Lots
495.1500/ 1
Open / Previous Close
0.0000 / 311.4200
Day Range
---
52 Week Range
Low 215.9600
High 335.8300
Volume
14
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 2 minutes ago by MT Newswires
  2 minutes ago by MT Newswires
  Companies Mentioned: HCA
  07:01 AM EDT, 04/30/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
Yesterday
- DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 19 hours ago by Dow Jones
  19 hours ago by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 11:51 ET (15:51 GMT)
- DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 20 hours ago by Dow Jones
  20 hours ago by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 10:17 ET (14:17 GMT)
- Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: HCA
  09:29 AM EDT, 04/29/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average outperform rating and a price target range of $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ...
- UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating, from 21 hours ago by MT Newswires
  21 hours ago by MT Newswires
  Companies Mentioned: HCA
  09:22 AM EDT, 04/29/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $285 to $378, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...

Today
- BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: WELL
Yesterday
- Welltower Q1 Normalized FFO, Revenue Increase, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: WELL
- -- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: WELL
- Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 15 hours ago by MT Newswires
  15 hours ago by MT Newswires
  Companies Mentioned: WELL, KO, LLY, LOGI, MCD, PFE, NXPI, AAPL, PARA, PARAA, AMD, AMZN, MA
- Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 20 hours ago by MT Newswires
  20 hours ago by MT Newswires
  Companies Mentioned: LH, PFE
- Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 23 hours ago by MT Newswires
  23 hours ago by MT Newswires
  Companies Mentioned: VTR
- Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 23 hours ago by PR Newswire
  23 hours ago by PR Newswire
  Companies Mentioned: LH
Apr 26, 2024
- Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255, from 11:14AM ET on Friday Apr 26, 2024 by MT Newswires
  11:14AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: LH
- Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234, from 10:34AM ET on Friday Apr 26, 2024 by MT Newswires
  10:34AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: LH
- Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating, from 7:55AM ET on Friday Apr 26, 2024 by MT Newswires
  7:55AM ET on Friday Apr 26, 2024 by MT Newswires
  Companies Mentioned: LH

HCA Healthcare Inc
NYSE:HCAUnited States

Search Criteria

Today

TD Cowen Adjusts Price Target on HCA Healthcare to $360 From $371, from 2 minutes ago by MT Newswires

Yesterday

DJ HCA Healthcare Is Maintained at Overweight by Barclays, from 19 hours ago by Dow Jones

DJ HCA Healthcare Is Maintained at Outperform by RBC Capital, from 20 hours ago by Dow Jones

Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354, from 21 hours ago by MT Newswires

UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating, from 21 hours ago by MT Newswires

Peers Headlines

Today

BNP Paribas Exane Adjusts Welltower's Price Target to $107 From $104, Keeps Outperform Rating, from 1 hour ago by MT Newswires

Yesterday

Welltower Q1 Normalized FFO, Revenue Increase, from 14 hours ago by MT Newswires

-- Earnings Flash (WELL) WELLTOWER Posts Q1 Revenue $1.86B, from 14 hours ago by MT Newswires

Equities Higher as Traders Await This Week's Key Earnings, Fed Decision, from 15 hours ago by MT Newswires

Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy, from 20 hours ago by MT Newswires

Evercore ISI Adjusts Price Target on Ventas to $49 From $50, from 23 hours ago by MT Newswires

Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B, from 23 hours ago by PR Newswire

Apr 26, 2024

Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255, from 11:14AM ET on Friday Apr 26, 2024 by MT Newswires

Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234, from 10:34AM ET on Friday Apr 26, 2024 by MT Newswires

Truist Cuts Price Target on Laboratory Corp of America Holdings to $255 From $270, Keeps Buy Rating, from 7:55AM ET on Friday Apr 26, 2024 by MT Newswires